Joseph Leveque

Joseph A. Leveque currently works at Medikine, Inc., as President, Chief Executive Officer & Director from 2022 and ImmunOs Therapeutics AG, as Director from 2022.
Dr. Leveque also formerly worked at Amgen, Inc., as Medical Director from 2005 to 2007, Bristol Myers Squibb Co., as Vice President from 2011 to 2015, Cephalon, Inc., as VP-Oncology Medical & Scientific Affairs from 2007 to 2009, Onyx Pharmaceuticals, Inc., as Vice President-Medical & Scientific Affairs from 2009 to 2011, Mirati Therapeutics, Inc., as Chief Medical Officer & Executive Vice President from 2020 to 2021, EMD Serono, Inc., as Chief Medical Officer from 2015 to 2017, ARMO BioSciences, Inc., as Chief Medical Officer from 2017 to 2018, and Synthorx, Inc., as Chief Medical Officer from 2018 to 2020.
Dr. Leveque received his doctorate degree from The University of Texas at Austin, undergraduate degree from Santa Clara University, and Masters Business Admin degree from The Wharton School of the University of Pennsylvania.